Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Clovis Oncology Inc (NASDAQ:CLVS)

62.90
Delayed Data
As of Dec 11
 +0.75 / +1.21%
Today’s Change
35.38
Today|||52-Week Range
99.45
+41.60%
Year-to-Date

Today’s Trading

Previous close62.15
Today’s open62.50
Day’s range61.83 - 65.35
Volume1,402,672
Average volume (3 months)1,407,162
Market cap$3.0B
Data as of 4:00pm ET, 12/11/2017

Growth & Valuation

Earnings growth (last year)+7.35%
Earnings growth (this year)+15.91%
Earnings growth (next 5 years)-71.23%
Revenue growth (last year)--
P/E ratioNM
Price/Sales21,912.70
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PTLAPortola Pharmaceutic...-1.24-2.34%
OPKOPKO Health Inc-0.10-1.90%
PBYIPuma Biotechnology I...+0.40+0.40%
MNKMallinckrodt Plc+0.84+3.77%
Data as of 4:02pm ET, 12/11/2017

Financials

Next reporting dateMarch 1, 2018
EPS forecast (this quarter)-$1.28
Annual revenue (last year)$78.0K
Annual profit (last year)-$349.1M
Net profit margin-447,611.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Patrick J. Mahaffy
Principal Financial Officer &
SVP-Finance
Daniel W. Muehl
Corporate headquarters
Boulder, Colorado

Forecasts